Lambda-Plus

Name

Lambda-Plus

Legal name

LambdaPlus

Website

https://lambdaplus.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Clinical Trial Management Software (eClinical Platform)

NAICS

Software Publishers (5132), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industry

Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL)

Keywords

• Clinical trial software
• EClinical platform
• Electronic data capture
• Clinical research technology
• Regulatory compliance software

Headquarters

HQ city

Isnes

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. SaaS Subscription (Starter & Professional): Monthly subscription model with tiered pricing. Starter tier is free for 14 days; Professional tier is Rp 2.9Jt/month. Subscriptions include access to core modules like eCRF, ePRO, randomization, and analytics.
2. Project-Based Licensing: Per-project licensing option for studies with defined scope. Available alongside SaaS model. Includes core modules and is suitable for one-off or smaller studies.
3. Enterprise Custom Contracts: Annual custom contracts for CROs and multinational sponsors. Includes unlimited studies, all modules, AI analytics, custom HL7 integration, on-premise/hybrid deployment, and dedicated account management.
4. Professional Services: Training, onboarding support, hosting services, and technical integration assistance included across tiers. Enterprise includes dedicated account manager and customized onboarding programs.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels3 records

Core offering

LambdaPlus is a modular eClinical Software-as-a-Service platform that supports the full lifecycle of clinical research, including electronic Case Report Forms (eCRF), electronic Patient-Reported Outcomes (ePRO), randomization, electronic Trial Master File (eTMF), electronic consent, DICOM imaging with anonymization, and AI-powered analytics. The platform is sold to research sponsors, Contract Research Organizations (CROs), and healthcare institutions on tiered SaaS subscriptions, project-based licensing, or custom annual enterprise contracts, with deployment available as cloud SaaS, on-premise, or hybrid.

Product overview

LambdaPlus is a modular eClinical platform offering a unified suite of clinical research tools available in SaaS (subscription cloud) and project-based modes. The core platform is LambdaPlus itself, which integrates multiple purpose-built modules: eCRF & Designer for electronic case report forms, ePRO for patient-reported outcomes, Randomisasi for subject randomization, eTMF for trial master file management, eConsent for electronic informed consent, Analitik AI for machine learning-powered analytics and predictive dashboards, and Imaging DICOM for clinical imaging management with anonymization. Additional features include SDTM mapping for CDISC-compliant regulatory submissions. The platform supports multi-center international trials across 64+ countries with deployment options ranging from cloud SaaS to on-premise or hybrid configurations.

Differentiator

Problem solved

Functional benefit

Products and services

• LambdaPlus Platform

Quantifiable outcome

• eCRF processes significantly faster and more accurate according to user reviews
• +2 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability3 records

Feature10 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Veeva Systems: Veeva Vault CTMS and Vault EDC are industry-leading eClinical suites serving global pharma sponsors and CROs. LambdaPlus competes with Veeva in the same clinical trial technology category, targeting similar sponsor and CRO buyers with a more modular, lower-priced platform.
• Medidata Solutions (Dassault Systèmes): Medidata's Rave EDC, Rave ePRO, and broader Medidata Platform are the de facto standard in enterprise eClinical. LambdaPlus' eCRF, ePRO, and randomization modules compete directly with Rave in multi-center international trials for pharma and CRO customers.
• Clinion: Clinion delivers an eClinical platform with EDC, ePRO, RTSM, and eTMF modules for pharma and CRO clients globally, with strong presence in Asia-Pacific. Overlapping module coverage and similar regional focus make Clinion a direct peer, particularly in SEA markets.
• Castor: Castor offers a modular eClinical platform with EDC, ePRO, eConsent, and decentralized trial features for global sponsors and CROs. Comparable modular architecture, mid-market focus, and product-led growth motion make it a direct peer to LambdaPlus.
• Oracle Clinical One: Oracle's Clinical One Platform is a unified eClinical suite (EDC, RTSM, ePRO, eTMF) targeting the same pharma sponsor and CRO buyer as LambdaPlus. Comparable module coverage and similar global deployment positioning make it a direct competitor for enterprise deals.
• Viedoc: Viedoc provides a cloud-based eClinical suite with EDC, ePRO, eTMF, and eConsent for global clinical trials. Comparable module set, SaaS delivery, and emphasis on multi-country trials position Viedoc as a direct competitor to LambdaPlus for sponsor and CRO customers.
• Clinical Ink: Clinical Ink provides eCOA, ePRO, and clinical trial technology platforms including EDC and eConsent for global pharma and CROs. Overlapping ePRO and consent capabilities position Clinical Ink as a direct peer for clinical-data capture and patient-centric trials.
• Medrio: Medrio offers cloud-based EDC, ePRO, and eConsent for clinical trials with a strong SMB and mid-market focus. Comparable modular offering and similar pricing-tier philosophy make Medrio a direct peer in the segment where LambdaPlus Professional tier competes.
• OpenClinica: OpenClinica provides EDC, ePRO, and eClinical data management for clinical trials, with both open-source and enterprise editions. Comparable EDC-focused functionality and similar target customer mix make OpenClinica a direct competitor for LambdaPlus' mid-market customers.

Emerging players

• REDCap: REDCap is a widely deployed open-source EDC platform used heavily by academic medical centers and investigator-initiated trials. While not a commercial enterprise vendor, it directly competes with LambdaPlus' Starter and Professional tiers in the academic and individual researcher segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lambda-Plus